Immediate Impact

51 standout
Sub-graph 1 of 24

Citing Papers

A guide to artificial intelligence for cancer researchers
2024 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
1 intermediate paper

Works of Nicolas Scheuer being referenced

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
2022
Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data
2021

Author Peers

Author Last Decade Papers Cites
Nicolas Scheuer 47 47 135 101 55 12 291
Eizaburo Sueoka 52 22 108 78 21 20 288
Annie Hung 121 30 48 34 28 30 313
Meredith Buxton 83 36 54 23 13 13 172
Ruoyan Gai Tobe 21 18 142 82 16 22 328
Ray Gani 16 42 100 17 33 16 310
Reinhild Strauß 56 5 161 147 20 20 285
Yun-Jau Chang 109 45 52 67 37 18 290
Madhulika Mistry 121 53 71 16 58 11 287
Bin Zhou 44 52 69 135 52 15 319
Reiner Banken 33 13 54 56 47 10 291

All Works

Loading papers...

Rankless by CCL
2026